APHESIS
Mark Identification

APHESIS

Serial Number

85700753

Filing Date

Aug 10, 2012

Trademark by

STRATEGICON PARTNERS LLC

Classification Information

House mark for a full line of pharmaceuticals; pharmaceuticals for use in prevention, treatment and diagnosis of cardiovascular, autoimmune and neurological diseases, and for viral, cancer, nervous system, metabolic system, musculo-skeletal system, hematological, inflammatory, gastroenterological, respiratory and transplantation-related diseases and disorders; pharmaceuticals for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation; pharmaceuticals for use in modulating weight loss, regulating reproductive function and promoting wound healing, and for use in the treatment of obesity, diabetes, hypertension, dyslipidemia, hormonal disorders, sexual dysfunction and infertility; preparations for detecting genetic predispositions for medical purposes

Pharmaceuticals

Pharmaceutical and biotechnological research and development and product evaluation; consulting services in the fields of biotechnology, pharmaceutical research and development, genetic science, laboratory testing, diagnostics and pharmacogenetics; genetic mapping and testing for scientific purposes; scientific research in the field of genetics and genetic engineering; medical and scientific research, namely, conducting clinical trials and evaluations in the field of new pharmaceuticals; development of new technology for others in the fields of genomics and biotechnology; research and development of technologies for the prevention, treatment and diagnosis of cardiovascular, autoimmune and neurological diseases, and for viral, cancer, nervous system, metabolic system, musculo-skeletal system, hematological, inflammatory, gastroenterological, respiratory and transplantation-related diseases and disorders; research and development of technologies for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation; research and development of technologies for use in modulating weight loss, regulating reproductive function and promoting wound healing, and for use in the treatment of obesity, diabetes, hypertension, dyslipidemia, hormonal disorders, sexual dysfunction and infertility; biotechnology research, namely, pharmaceutical product research and development of drug therapies and diagnostic tests for the prevention and treatment of cardiovascular, autoimmune and neurological diseases, and for viral, cancer, nervous system, metabolic system, musculo-skeletal system, hematological, inflammatory, gastroenterological, respiratory and transplantation-related diseases and disorders

Computer and Scientific